Safety Alerts & Recalls
Search all Safety Alerts & Recalls
Latest Alerts
Sanofi-aventis US, Inc. Recalls Several Lots of Lantus
Sanofi-aventis US, Inc. has recalled several lots of Lantus (insulin glargine [rDNA origin] injection) 10 mL. The following lot numbers have been recalled because the vials in these lots may not be sterile: A1259, A1271, and A1295.
Lantus contains the active ingredient insulin glargine and is commonly used in the treatment of diabetes. This recall alert only applies to the select lots of Lantus (insulin glargine [rDNA origin] injection) 10 mL from the 3 lots listed above. No other Lantus products were involved in this recall.
To view the FDA notice about this recall, please visit:
http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm285791.htm
Learn More
Glenmark Generics Inc. Recalls Single Lot of Glenmark Clotrimazole Cream
Glenmark Generics Inc. has recalled a single lot of Glenmark Clotrimazole Cream USP, 1%, 30g. Lot number 02111245 has been recalled because the tube was incorrectly labeled with the drug name Ciclopirox.
Clotrimazole is used in the treatment of fungal infections. Clotrimazole is also sold under other brand names, formulations and through other manufacturers. No other lots, strengths, formulations or brands of Clotrimazole were involved in this recall.
To view the FDA notice about this recall, please visit:
http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm285791.htm
Learn More